WO2022073966A3 - Verfahren und vorrichtung zur herstellung von universalplasma - Google Patents

Verfahren und vorrichtung zur herstellung von universalplasma Download PDF

Info

Publication number
WO2022073966A3
WO2022073966A3 PCT/EP2021/077371 EP2021077371W WO2022073966A3 WO 2022073966 A3 WO2022073966 A3 WO 2022073966A3 EP 2021077371 W EP2021077371 W EP 2021077371W WO 2022073966 A3 WO2022073966 A3 WO 2022073966A3
Authority
WO
WIPO (PCT)
Prior art keywords
antibodies
blood plasma
plasma depleted
relates
preparing
Prior art date
Application number
PCT/EP2021/077371
Other languages
English (en)
French (fr)
Other versions
WO2022073966A2 (de
Inventor
Andreas Greinacher
Konstanze Aurich
Original Assignee
Universität Greifswald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universität Greifswald filed Critical Universität Greifswald
Priority to CA3197820A priority Critical patent/CA3197820A1/en
Priority to EP21786928.8A priority patent/EP4225329A2/de
Publication of WO2022073966A2 publication Critical patent/WO2022073966A2/de
Publication of WO2022073966A3 publication Critical patent/WO2022073966A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0281—Apparatus for treatment of blood or blood constituents prior to transfusion, e.g. washing, filtering or thawing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)

Abstract

Die vorliegende Erfindung betrifft in einem ersten Aspekt ein Verfahren zur Herstellung von Blutplasma, welches an Anti-A-Antikörpern und/oder Anti-B-Antikörpern abgereichert ist. Die Erfindung betrifft weiterhin in einem zweiten Aspekt ein an Anti-A-Antikörpern und/oder Anti-B- Antikörpern abgereichertes Blutplasma erhalten oder erhältlich nach dem Verfahren des ersten Aspektes. Gemäß eines dritten Aspektes betrifft die Erfindung die Verwendung eines an Anti-A- Antikörpern und/oder Anti-B-Antikörpern abgereicherten Blutplasmas erhalten oder erhältlich nach dem Verfahren des ersten Aspektes oder eines an Anti-A-Antikörpern und/oder Anti-B- Antikörpern abgereicherten Blutplasmas gemäß dem zweiten Aspekt. Weiterhin betrifft die Erfindung ein an Anti-A-Antikörpern und/oder Anti-B-Antikörpern abgereichertes Blutplasma oder ein an Anti-A-Antikörpern und/oder Anti-B-Antikörpern abgereichertes Blutplasma gemäß dem zweiten Aspekt zur Verwendung in einem therapeutischen oder einem in-vivo diagnostischen oder einem chirurgischen Verfahren. Ein vierter Aspekt der Erfindung bezieht sich auf eine Vorrichtung zur Herstellung von Blutplasma, welches an Anti-A-Antikörpern und/oder Anti-B-Antikörpern abgereichert ist.
PCT/EP2021/077371 2020-10-06 2021-10-05 Verfahren und vorrichtung zur herstellung von universalplasma WO2022073966A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA3197820A CA3197820A1 (en) 2020-10-06 2021-10-05 Method and device for preparing universal plasma
EP21786928.8A EP4225329A2 (de) 2020-10-06 2021-10-05 Verfahren und vorrichtung zur herstellung von universalplasma

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102020212609.7A DE102020212609B3 (de) 2020-10-06 2020-10-06 Verfahren und Vorrichtung zur Herstellung von Universalplasma
DE102020212609.7 2020-10-06

Publications (2)

Publication Number Publication Date
WO2022073966A2 WO2022073966A2 (de) 2022-04-14
WO2022073966A3 true WO2022073966A3 (de) 2022-07-21

Family

ID=78080334

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2021/077371 WO2022073966A2 (de) 2020-10-06 2021-10-05 Verfahren und vorrichtung zur herstellung von universalplasma

Country Status (4)

Country Link
EP (1) EP4225329A2 (de)
CA (1) CA3197820A1 (de)
DE (1) DE102020212609B3 (de)
WO (1) WO2022073966A2 (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0276342A1 (de) * 1984-07-19 1988-08-03 Xoma Corporation Methode zur Behandlung von Plasma und dessen Produkten
DE69325948T2 (de) * 1992-05-28 2000-01-20 New York Blood Center Inc Entfernung von Antikörpern aus von Blut stammenden Zusammensetzungen unter Erhalt von Gerinnungsfaktoren
DE69808620T2 (de) * 1997-08-05 2003-06-26 Octapharma Ag Lachen Universell verwendbares bluttplasma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007100294A1 (en) 2006-02-28 2007-09-07 Kurt Nilsson Material system for blood products
JP5695574B2 (ja) 2009-11-10 2015-04-08 テルモ株式会社 血液バッグシステム及び血液処理方法
US9033948B2 (en) 2011-04-19 2015-05-19 Fenwel, Inc. Single collection bag blood collection system, method and apparatus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0276342A1 (de) * 1984-07-19 1988-08-03 Xoma Corporation Methode zur Behandlung von Plasma und dessen Produkten
DE69325948T2 (de) * 1992-05-28 2000-01-20 New York Blood Center Inc Entfernung von Antikörpern aus von Blut stammenden Zusammensetzungen unter Erhalt von Gerinnungsfaktoren
DE69808620T2 (de) * 1997-08-05 2003-06-26 Octapharma Ag Lachen Universell verwendbares bluttplasma

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BRACKER: "A", 1 July 2005 (2005-07-01), XP055874807, Retrieved from the Internet <URL:http://vetfolio-vetstreet.s3.amazonaws.com/mmah/d4/9c1a1527c04c91a184e0a06ea09785/filePV_27_07_500.pdf> [retrieved on 20211220] *
HARALD NODDELAND ET AL: "Universal solvent/detergent-treated fresh frozen plasma (Uniplas )—rationale and clinical properties", THROMBOSIS RESEARCH, vol. 107, 1 October 2002 (2002-10-01), AMSTERDAM, NL, pages S33 - S37, XP055253251, ISSN: 0049-3848, DOI: 10.1016/S0049-3848(02)00150-0 *

Also Published As

Publication number Publication date
EP4225329A2 (de) 2023-08-16
CA3197820A1 (en) 2022-04-14
WO2022073966A2 (de) 2022-04-14
DE102020212609B3 (de) 2022-04-07

Similar Documents

Publication Publication Date Title
TR201905882T4 (tr) Dağıtım aparatı.
MX2021009245A (es) Metodos de preparacion de nanoparticulas lipidicas.
MX2019005125A (es) Variantes de superficie celular discernibles inmunologicamente para uso en terapia celular.
CO2017000571A2 (es) Procedimiento de inactivación de inmunoglobulina endógena que permite facilitar procedimientos médicos que se ven afectados por la presencia de inmunoglobulina endógena
NZ769319A (en) Respiratory pressure therapy system
WO2014074477A3 (en) Magnetic contact lenses and methods of treatment and diagnosis using the same
MY174772A (en) Human antibodies to respiratory syncytial virus f protein and methods of use thereof
MY175997A (en) Antl-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
CY1121222T1 (el) Ιατρικη κολλα και μεθοδος παραγωγης της
WO2022073966A3 (de) Verfahren und vorrichtung zur herstellung von universalplasma
WO2011163512A3 (en) Cancer therapy
WO2018067946A8 (en) METHODS OF TREATING PATIENTS USING RETINOIC ACID ALPHA RECEPTOR AGONIST AND ANTI-CD38 ANTIBODY
EP4027872A4 (de) System und verfahren zum nichtinvasiven messen von blutvolumenschwingungen im schädel eines menschen
MX2021011328A (es) Método para tratar la psoriasis en sujetos pediátricos con anticuerpo anti-il12/il23.
WO2021257695A3 (en) Methods and compositions related to neutralizing antibodies against human coronavirus
WO2023084048A3 (en) Microfluidic preparation of fluorocarbon cross-linked vesicles
EP3930566A4 (de) System zur nichtinvasiven untersuchung von parametern der blutumgebung
Jung et al. Catastrophic Pulmonary Embolism Despite Negative Ultrasonography for Deep Vein Thrombosis in the Patient after Posterior Thoracic Fusion Surgery
Yıldırım et al. Fantom ekstremite ağrısının yönetiminde ayna terapisinin etkisi
EP4196715A4 (de) Halter für einen monitor, anordnung aus halter und monitor, extrakorporale blutbehandlungsvorrichtung und verwendung des halters
Singh et al. A study to evaluate the effectiveness of clonidine vs atenolol in providing optimal surgical field in nasal surgeries under general anaesthesia
UA79123U (ru) Способ ранней диагностики метаэпифизарного остеомиелита у детей
UA85188U (ru) Способ оценки состояния больных с нестабильностью шейного отдела позвоночника, сопровождающейся цефалгией
MX2023000732A (es) Anticuerpos anti- alfa-4-beta-7.
Fujita et al. A Case of Ear Pick Injury in which 3D-CT was Useful for Diagnosis and Treatment

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21786928

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 3197820

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2021786928

Country of ref document: EP

Effective date: 20230508